ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024
VSTM2A reverses immunosuppression in colorectal cancer by antagonizing the PD-L1/PD-1 interaction.
Yujuan Dong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.